These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 12636166

  • 21. Dermal peptide delivery using enhancer molecules and colloidal carrier systems--part I: carnosine.
    Goebel AS, Schmaus G, Neubert RH, Wohlrab J.
    Skin Pharmacol Physiol; 2012; 25(6):281-7. PubMed ID: 22890441
    [Abstract] [Full Text] [Related]

  • 22. Microemulsion as a tool for the transdermal delivery of ondansetron for the treatment of chemotherapy induced nausea and vomiting.
    Al Abood RM, Talegaonkar S, Tariq M, Ahmad FJ.
    Colloids Surf B Biointerfaces; 2013 Jan 01; 101():143-51. PubMed ID: 22796784
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Biomedical applications of microemulsion through dermal and transdermal route.
    Shukla T, Upmanyu N, Agrawal M, Saraf S, Saraf S, Alexander A.
    Biomed Pharmacother; 2018 Dec 01; 108():1477-1494. PubMed ID: 30372850
    [Abstract] [Full Text] [Related]

  • 26. [Microemulsion-based gel of fluorouracil for transdermal delivery].
    Xiao YY, Liu F, Chen ZP, Ping QN.
    Yao Xue Xue Bao; 2010 Nov 01; 45(11):1440-6. PubMed ID: 21361046
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Formulation of a cosurfactant-free O/W microemulsion using nonionic surfactant mixtures.
    Cho YH, Kim S, Bae EK, Mok CK, Park J.
    J Food Sci; 2008 Apr 01; 73(3):E115-21. PubMed ID: 18387105
    [Abstract] [Full Text] [Related]

  • 31. An in vitro and in vivo comparison of solid and liquid-oil cores in transdermal aconitine nanocarriers.
    Zhang YT, Wu ZH, Zhang K, Zhao JH, Ye BN, Feng NP.
    J Pharm Sci; 2014 Nov 01; 103(11):3602-3610. PubMed ID: 25187419
    [Abstract] [Full Text] [Related]

  • 32. Nanoemulsion system for the transdermal delivery of a poorly soluble cardiovascular drug.
    Dixit N, Kohli K, Baboota S.
    PDA J Pharm Sci Technol; 2008 Nov 01; 62(1):46-55. PubMed ID: 18402367
    [Abstract] [Full Text] [Related]

  • 33. Development of Microemulsion Based Nabumetone Transdermal Delivery for Treatment of Arthritis.
    Jagdale SC, Deore GK, Chabukswar AR.
    Recent Pat Drug Deliv Formul; 2018 Nov 01; 12(2):130-149. PubMed ID: 29485013
    [Abstract] [Full Text] [Related]

  • 34. A delivery system to avoid self-aggregation and to improve in vitro and in vivo skin delivery of a phthalocyanine derivative used in the photodynamic therapy.
    Rossetti FC, Lopes LB, Carollo AR, Thomazini JA, Tedesco AC, Bentley MV.
    J Control Release; 2011 Nov 07; 155(3):400-8. PubMed ID: 21763732
    [Abstract] [Full Text] [Related]

  • 35. Ionic liquids as ingredients in topical drug delivery systems.
    Dobler D, Schmidts T, Klingenhöfer I, Runkel F.
    Int J Pharm; 2013 Jan 30; 441(1-2):620-7. PubMed ID: 23123180
    [Abstract] [Full Text] [Related]

  • 36. Application of Design Expert for the investigation of capsaicin-loaded microemulsions for transdermal delivery.
    Duangjit S, Chairat W, Opanasopit P, Rojanarata T, Ngawhirunpat T.
    Pharm Dev Technol; 2016 Sep 30; 21(6):698-705. PubMed ID: 25996630
    [Abstract] [Full Text] [Related]

  • 37. Microemulsion Transdermal Formulation for Simultaneous Delivery of Valsartan and Nifedipine: Formulation by Design.
    Sood J, Sapra B, Tiwary AK.
    AAPS PharmSciTech; 2017 Aug 30; 18(6):1901-1916. PubMed ID: 27858253
    [Abstract] [Full Text] [Related]

  • 38. PREPARATION, IN VITRO AND IN VIVO CHARACTERIZATION OF HYDROPHOBIC PATCHES OF A HIGHLY WATER SOLUBLE DRUG FOR PROLONGED PLASMA HALF LIFE: EFFECT OF PERMEATION ENHANCERS.
    Yaqoob A, Ahmad M, Mahmood A, Sarfraz RM.
    Acta Pol Pharm; 2016 Nov 30; 73(6):1639-1648. PubMed ID: 29634120
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.
    Zorec B, Zupančič Š, Kristl J, Pavšelj N.
    Eur J Pharm Biopharm; 2018 Jun 30; 127():387-397. PubMed ID: 29581043
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.